MPO and Sepsis: Treatment with montelukast, a CysLT1 receptor antagonist, was previously shown to prevent the rise of MPO activity, GSH depletion, and lipid peroxidation in the liver of septic rats, suggesting that neutrophilic infiltration into tissues is a major contributor to sepsis-induced oxidative stress [54,55,80].